Galectin-9 in physiological and pathological conditions
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 19 (7-9) , 593-600
- https://doi.org/10.1023/b:glyc.0000014090.63206.2f
Abstract
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings. Published in 2004.Keywords
This publication has 36 references indexed in Scilit:
- Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 PathwayThe Journal of Immunology, 2003
- Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?Published by Elsevier ,2002
- Possible role of galectin‐9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significanceInternational Journal of Cancer, 2002
- Regulation of galectin-9 expression and release in Jurkat T cell line cellsGlycobiology, 2002
- Requirement of Divalent Galactoside-binding Activity of Ecalectin/Galectin-9 for Eosinophil ChemoattractionJournal of Biological Chemistry, 2000
- Activation of Signaling Pathways and Prevention of Apoptosis by Cytokines in EosinophilsInternational Archives of Allergy and Immunology, 1997
- Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.Journal of Clinical Investigation, 1996
- Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils.1992
- Eosinophil Chemotactic Factors From Granuloma of Kimura's Disease, With Special Reference to T Lymphocyte-Derived FactorsJournal of Leukocyte Biology, 1986
- THE REGULATION OF TISSUE EOSINOPHILIA .3. INVITRO PRODUCTION OF EOSINOPHIL-DIRECTED CHEMOTACTIC INHIBITORY FACTOR BY LYMPHOCYTES-T OF COMPLETE FREUND ADJUVANT-TREATED GUINEA-PIGS1985